Stocktoria
SUPERNUS PHARMACEUTICALS, INC. SUPN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-12-28
SUPERNUS PHARMACEUTICALS, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 10,392,636 | $278.0M |
| MILLENNIUM MANAGEMENT LLC | 3,315,973 | $171.4M |
| RENAISSANCE TECHNOLOGIES LLC | 1,705,222 | $88.1M |
| CITADEL ADVISORS LLC | 1,528,046 | $79.0M |
| Point72 Asset Management, L.P. | 1,318,555 | $68.2M |
| D. E. Shaw & Co., Inc. | 622,450 | $32.2M |
| TWO SIGMA INVESTMENTS, LP | 271,228 | $14.0M |
| AQR CAPITAL MANAGEMENT LLC | 98,257 | $5.1M |
Source: SEC EDGAR filings · CIK 0001356576 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.